11th Circ. Undermined Rare-Disease Drugs, High Court Told
By Adam Lidgett ( April 12, 2022, 7:27 PM EDT) -- Jacobus Pharmaceutical Co. Inc. said that the Eleventh Circuit created a circuit split and upended years of U.S. Food and Drug Administration policy when it ruled lucrative exclusivity for so-called orphan drugs extends not just to the specific approved uses but rather the entire drug....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.